2.21
price up icon12.76%   0.25
after-market Handel nachbörslich: 2.27 0.06 +2.71%
loading
Schlusskurs vom Vortag:
$1.96
Offen:
$2
24-Stunden-Volumen:
1.57M
Relative Volume:
3.20
Marktkapitalisierung:
$156.82M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-117.50M
KGV:
-0.9208
EPS:
-2.4
Netto-Cashflow:
$-114.31M
1W Leistung:
+5.74%
1M Leistung:
+20.77%
6M Leistung:
+4.25%
1J Leistung:
-55.53%
1-Tages-Spanne:
Value
$2.00
$2.26
1-Wochen-Bereich:
Value
$1.955
$2.26
52-Wochen-Spanne:
Value
$1.31
$6.6279

Nkarta Inc Stock (NKTX) Company Profile

Name
Firmenname
Nkarta Inc
Name
Telefon
(925) 407-1049
Name
Adresse
1150 VETERANS BOULEVARD, SOUTH SAN FRANCISCO
Name
Mitarbeiter
157
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-26
Name
Neueste SEC-Einreichungen
Name
NKTX's Discussions on Twitter

Vergleichen Sie NKTX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
NKTX
Nkarta Inc
2.21 142.62M 0 -117.50M -114.31M -2.40
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
395.92 99.42B 11.42B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
561.55 58.99B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
432.52 56.35B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
646.60 39.02B 3.05B 1.28B -614.78M 19.58
Biotechnology icon
ONC
Beone Medicines Ltd Adr
307.51 34.25B 3.81B -644.79M -669.77M -6.24

Nkarta Inc Stock (NKTX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-05-15 Herabstufung William Blair Outperform → Mkt Perform
2024-10-09 Eingeleitet Rodman & Renshaw Buy
2024-08-14 Hochstufung Raymond James Outperform → Strong Buy
2024-03-22 Herabstufung Raymond James Strong Buy → Outperform
2022-12-22 Herabstufung Oppenheimer Outperform → Perform
2022-10-10 Eingeleitet Canaccord Genuity Buy
2022-07-28 Eingeleitet Needham Buy
2022-07-18 Eingeleitet SVB Leerink Outperform
2022-03-11 Eingeleitet Raymond James Outperform
2022-03-08 Eingeleitet H.C. Wainwright Buy
2022-01-06 Eingeleitet William Blair Outperform
2021-11-18 Eingeleitet SMBC Nikko Outperform
2021-07-16 Eingeleitet Oppenheimer Outperform
2020-08-04 Eingeleitet Cowen Outperform
2020-08-04 Eingeleitet Evercore ISI Outperform
2020-08-04 Eingeleitet Mizuho Buy
2020-08-04 Eingeleitet Stifel Buy
Alle ansehen

Nkarta Inc Aktie (NKTX) Neueste Nachrichten

pulisher
09:25 AM

Combining price and volume data for Nkarta Inc.Earnings Trend Report & High Accuracy Trade Alerts - Newser

09:25 AM
pulisher
09:01 AM

Is Nkarta Inc. showing signs of accumulationTreasury Yields & Technical Analysis for Trade Confirmation - Newser

09:01 AM
pulisher
08:12 AM

Analyzing recovery setups for Nkarta Inc. investors2025 Price Targets & Weekly Stock Breakout Alerts - Newser

08:12 AM
pulisher
06:37 AM

Can Nkarta Inc. rally from current levelsWeekly Gains Report & Real-Time Market Sentiment Alerts - Newser

06:37 AM
pulisher
01:36 AM

Historical volatility pattern of Nkarta Inc. visualizedPrice Action Summary and Entry Strategy Guide - Newser

01:36 AM
pulisher
01:25 AM

Nkarta Reports Second Quarter 2025 Financial Results and Corporate Highlights - GlobeNewswire

01:25 AM
pulisher
12:27 PM

Quantitative breakdown of Nkarta Inc. recent move [Jobs Report]Free Accurate Buy Signal Notifications - Newser

12:27 PM
pulisher
12:25 PM

Nkarta's chief technical officer sells $16,383 in stock - MSN

12:25 PM
pulisher
12:19 PM

Nkarta, Inc. Reports Q2 2025 Financial Results - TipRanks

12:19 PM
pulisher
Aug 12, 2025

Nkarta Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 12, 2025
pulisher
Aug 12, 2025

Nkarta's $334M Cash Runway Extends to 2029 as Autoimmune Treatment Trials Advance - Stock Titan

Aug 12, 2025
pulisher
Aug 12, 2025

Building trade automation scripts for Nkarta Inc.Strong Buy Opportunity with Volume Support - Newser

Aug 12, 2025
pulisher
Aug 11, 2025

Institutional scanner results for Nkarta Inc.Growth Projection Summary for Long-Term Investors - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

Risk vs reward if holding onto Nkarta Inc.AI Powered Buy Point Forecast Planner - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

Is it too late to sell Nkarta Inc.Free Entry Alert With Low Drawdown Strategy - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

Applying sector rotation models to Nkarta Inc.Free Investment Strategy With Predictable Gains - Newser

Aug 11, 2025
pulisher
Aug 10, 2025

Nkarta (NKTX) Projected to Post Quarterly Earnings on Tuesday - Defense World

Aug 10, 2025
pulisher
Aug 09, 2025

Nkarta NKTX 2025Q2 Earnings Preview Upside Potential Driven by Strategic Platform Expansion - AInvest

Aug 09, 2025
pulisher
Aug 09, 2025

What is the cash position of Nkarta Inc.Double Capital Strategy Picks - classian.co.kr

Aug 09, 2025
pulisher
Aug 09, 2025

Detecting price anomalies in Nkarta Inc. with AIReal Time Growth Signal with Smart Setup - Newser

Aug 09, 2025
pulisher
Aug 08, 2025

Is Nkarta Inc. trending in predictive chart modelsReal-Time Entry Forecast with Accuracy Metrics - Newser

Aug 08, 2025
pulisher
Aug 08, 2025

Custom strategy builders for tracking Nkarta Inc.Free Daily Top Performing Stock Insights - Newser

Aug 08, 2025
pulisher
Aug 08, 2025

How Nkarta Inc. stock performs during market volatilityFree AI Powered High Return Stock Calls - Newser

Aug 08, 2025
pulisher
Aug 07, 2025

How Interest Rate Changes Impact Nkarta Inc. Stock PerformanceFree Consistent Gain Investment Strategies - Newser

Aug 07, 2025
pulisher
Aug 05, 2025

Applying Wyckoff theory to Nkarta Inc. stockStrategy Chart for Real-Time Trade Flow - Newser

Aug 05, 2025
pulisher
Aug 04, 2025

Nkarta Inc. Enters Reversal Setup in Weekly ChartsFundamental + Technical Hybrid Stock Tips Shared - beatles.ru

Aug 04, 2025
pulisher
Aug 04, 2025

Quant Strategy Flags Nkarta Inc. for EntryEntry Points For Growing Stocks Identified by Models - metal.it

Aug 04, 2025
pulisher
Aug 04, 2025

What are analysts’ price targets for Nkarta Inc. in the next 12 monthsAccelerated capital growth - Jammu Links News

Aug 04, 2025
pulisher
Aug 03, 2025

Is Nkarta Inc. a growth stock or a value stockExceptional earning trajectories - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How strong is Nkarta Inc. company’s balance sheetMaximize gains with expert analysis - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What drives Nkarta Inc. stock priceMarket-crushing stock picks - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How volatile is Nkarta Inc. stock compared to the marketFastest-growing stock picks - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Published on: 2025-08-03 22:18:39 - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is Nkarta Inc. stock overvalued or undervaluedAchieve superior returns with professional insights - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What is Nkarta Inc. company’s growth strategyMaximize returns with strategic stock selection - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What catalysts could drive Nkarta Inc. stock higher in 2025Maximize returns with strategic stock selection - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What is the dividend policy of Nkarta Inc. stockMassive wealth growth - Jammu Links News

Aug 03, 2025
pulisher
Aug 02, 2025

What markets is Nkarta Inc. expanding into Is BML.PRH stock a good long term investment option - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

Price Clustering Detected in Nkarta Inc. StockReal Profit Trade Plan Suggestions Shared Widely - beatles.ru

Aug 02, 2025
pulisher
Aug 01, 2025

What makes Nkarta Inc. stock price move sharplyFundamental Analysis for Value Stock Selection - Newser

Aug 01, 2025

Finanzdaten der Nkarta Inc-Aktie (NKTX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Nkarta Inc-Aktie (NKTX) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Shook David
See Remarks
Jan 15 '25
Sale
2.20
8,638
19,004
190,955
Levin Alyssa
See Remarks
Jan 15 '25
Sale
2.20
5,838
12,844
102,662
Brandenberger Ralph
Chief Technical Officer
Jan 15 '25
Sale
2.20
7,447
16,383
124,796
HASTINGS PAUL J
Chief Executive Officer
Jan 15 '25
Sale
2.20
17,378
38,232
319,859
Hager Alicia J.
Chief Legal Officer
Jan 15 '25
Sale
2.20
9,584
21,085
146,735
$36.46
price up icon 1.67%
$85.85
price up icon 5.20%
$26.87
price up icon 4.61%
$122.87
price up icon 0.71%
$112.78
price up icon 1.60%
biotechnology ONC
$307.51
price up icon 6.74%
Kapitalisierung:     |  Volumen (24h):